This third edition is the product of the author's 25 years of experience with flow cytometry;
although it covers the wide spectrum of hematopoietic tumors, the focus remains on most …

Detection of minimal/measurable residual disease (MRD) in acute myeloid leukemia (AML)
is important for guiding patient‐specific clinical management. Natural killer (NK) cells can …

Almost half of adult acute myelogenous leukemia (AML) is normal cytogenetically, and this
subgroup shows a remarkable heterogeneity of genetic mutations at the molecular level and …

Flow cytometry (FCM) is being increasingly evaluated for the diagnosis of myelodysplastic
syndrome (MDS). We employed multiple FCM approaches to assess MDS. Five-color FCM …

目的探讨CD56 在甲状腺乳头状癌中的诊断价值. 方法采用免疫组化EnVision 法检测49
例甲状腺乳头状癌, 18 例结节性甲状腺肿和12 例甲状腺腺瘤中CD56 的表达. 结果49 …

We found 16 CD56+ cases (29.6%) among 54 acute myeloid leukemia (AML) patients; they
showed significantly Frequent cutaneous involvement compared to CD56‐cases (43.8% vs …

This study reports findings from a retrospective, comprehensive review of 80 cases of adult
AML in regard to cytomorphology, enzyme cytochemistry (EC), flow cytometric …

Because of the relative insensitivity of conventional cytogenetics for identifying abnormalities
in the non–chronic myelogenous leukemia (CML) myeloproliferative disorders (MPDs), we …

BACKGROUND AND OBJECTIVES. Myeloid leukemia of Down's syndrome (ML-DS) has
characteristic biological features (eg expression of the truncated GATA1s), which are …

CD56-positive nasal and nasal-type natural killer (NK)/T-cell lymphoma is now a well-
defined disease entity. Rare cases of blastic NK-cell lymphoma positive for CD56 have been …